- Pharmaceutical companies
- Shanghai Fosun Pharmaceutical
Shanghai Fosun Pharmaceutical
Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. Fosun Pharma also vigorously explores cutting-edge technologies, such as RNA, oncolytic viruses, gene therapy and PROTAC, to enhance its innovation capabilities.
For detailed contact information visit location pages below.
Shanghai Fosun Pharmaceutical's locations around the world
Clinical Trials sponsored by Shanghai Fosun Pharmaceutical
-
Shanghai Fosun Pharmaceutical Industrial Development...ReclutamentoMetastasi | Non-small Cell Lung Caner | KRAS-mutated | Previous TreamtedCina
-
Shanghai Fosun Pharmaceutical Industrial Development...Non ancora reclutamentoTumore Solido Refrattario al Trattamento ConvenzionaleCina
-
Shanghai Fosun Pharmaceutical Industrial Development...ReclutamentoIstiocitosi a cellule di Langerhans | LCHCina
-
Shanghai Fosun Pharmaceutical Industrial Development...Sospeso
-
Shanghai Fosun Pharmaceutical Industrial Development...TerminatoCancro avanzato | Tumori solidi | Leucemia mieloide acuta, in recidiva | Leucemia mieloide acuta refrattariaStati Uniti, Australia
-
Shanghai Fosun Pharmaceutical Industrial Development...Beijing Fosun Pharmaceutical Technology Development Co., Ltd.Attivo, non reclutanteSicurezza | Attività antitumorale | Profilo PKCina
-
Shanghai Fosun Pharmaceutical Industrial Development...Non ancora reclutamento
-
Shanghai Fosun Pharmaceutical Industrial Development...Non ancora reclutamentoLeucemia mieloide acuta | Sindromi mielodisplastiche | Leucemia linfoblastica acuta | Linfoma a cellule BCina
-
Shanghai Fosun Pharmaceutical Industrial Development...ReclutamentoUno studio clinico di fase II per valutare l'efficacia e la sicurezza di FXS5626 in pazienti con NIUUveite Non Anteriore, Non Infettiva AttivaCina
-
Shanghai Fosun Pharmaceutical Industrial Development...Non ancora reclutamento